About the job
Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a dynamic, well-funded biotechnology firm listed on Nasdaq. We provide an exciting opportunity to work in a fast-paced environment where you can influence our company culture and take on diverse responsibilities to foster your professional growth.
As a clinical-stage biotechnology company, we are pioneering novel biologics aimed at transforming treatment options in the largest Inflammation & Immunology (I&I) markets. Our antibody programs are meticulously designed to address the shortcomings of existing therapies by targeting established mechanisms of action while incorporating advanced engineering to enhance efficacy and dosing. Our lead program, Zumilokibart (APG777), focuses on treating atopic dermatitis and asthma, two areas with significant unmet needs. With a robust pipeline and a strong leadership team, Apogee is dedicated to delivering exceptional value and benefits to patients who are underserved by current standards of care.
We pride ourselves on our vibrant culture rooted in our C.O.R.E. values: Caring, Original, Resilient, and Egoless, with a steadfast commitment to excellence.
If this resonates with you, we invite you to explore further!We are on the lookout for an Associate Director of Biostatistics to assume a pivotal role as the statistical lead for one or multiple projects. In this capacity, you will provide technical leadership and statistical support throughout study design, project planning, and execution of clinical studies, including scientific publications. You will collaborate closely with cross-functional teams, delivering expert biostatistical insights into development plans, regulatory interactions, and study design. Key responsibilities may include authoring and reviewing the statistics sections in protocols, determining sample sizes, authoring and reviewing statistical analysis plans and mock tables, analyzing and interpreting clinical study results, and ensuring the integrity of statistical methodologies.

